3、 公司下游炭黑生产企业是否涉及导电炭黑或特种炭黑的生产？ 答：公司生产的炭黑装备可应用于导电炭黑及特种炭黑生产线，并已为黑 猫股份（SZ002068）、永东股份（SZ002753)、联科科技（SZ001207）等众多 知名炭黑企业的生产线提供过上述装备。未来，随着导电炭黑及特种炭黑应用 空间的持续拓展，也将对公司炭黑装备的销售起到一定的积极作用。 4、 公司毛利率保持较高水平的原因？ 证券代码：300950 证券简称：德固特 青岛德固特节能装备股份有限公司 投资者关系活动记录表 编号：2025-001 投资者关系活 动类别 □特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 □现场参观 ■其他（券商策略会） 参与单位名称 及人员姓名 华创证券 於尔东 中财招商 杨 旭 果行育德 宋海亮 时间 2025 年 5 月 7 日 15:30-16:30 地点 券商策略会会场（上海） 上市公司 接待人员姓名 董事、副总经理、财务总监、董事会秘书 高琳琳 投资者关系 活动主要内 容介绍 1、 公司 2024 年及 2025 年一季度业绩情况？ 答：2024 年度，公司实现营业收入 5.0 ...

Core Viewpoint - The company TOPcon is entering a harvest period for orders, with rapid revenue and performance growth expected in 2024 and Q1 2025. The company has established a business matrix in photovoltaic, semiconductor, and lithium battery equipment, actively working towards becoming a platform-type company [1]. Investment Highlights - The company is adjusting its EPS estimates for 2025 and 2026 to 6.31 and 4.19 CNY respectively, with a new EPS estimate for 2027 at 3.81 CNY. The target price is lowered to 69.41 CNY, maintaining a buy rating based on a 2025 PE of 11 times, compared to the average PE of 10.75 times for comparable companies [2]. - The company expects steady growth in 2024, with projected revenue of 18.887 billion CNY, a year-on-year increase of 116.26%, and a net profit of 2.764 billion CNY, up 69.18%. For Q1 2025, the revenue is expected to be 4.099 billion CNY, a year-on-year increase of 58.95%, with a net profit of 708 million CNY, up 22.42% [2]. Profitability Analysis - The company's profitability shows short-term fluctuations, with a gross margin of 26.46% and a net margin of 14.65% for 2024, reflecting year-on-year changes of -2.49 percentage points and -4.12 percentage points respectively. For Q1 2025, the gross margin and net margin are 27.52% and 17.28%, showing year-on-year declines of -5.42 percentage points and -5.21 percentage points [3]. - In terms of expense management, the company reported sales, management, R&D, and financial expense ratios of 0.88%, 1.14%, 3.44%, and -0.73% for 2024, with year-on-year changes of -1.75 percentage points, -0.93 percentage points, -1.91 percentage points, and +1.41 percentage points. For Q1 2025, these ratios were 0.85%, 0.96%, 3.95%, and -0.41%, with similar year-on-year changes [3]. Equipment Layout and Technological Development - The company is actively developing a technology platform across multiple sectors. In the photovoltaic equipment sector, it continues to innovate and improve product quality for new technology routes such as TOPCon, HJT, XBC, and perovskite. In the semiconductor equipment sector, its subsidiary has won orders for silicon carbide wet processing equipment, demonstrating the ability to replace imported equipment while expanding into the European and Asian markets [4]. - In the lithium battery equipment sector, the company has successfully launched its self-developed double-sided copper foil sputtering coating equipment and has delivered new vacuum winding aluminum foil coating equipment and thin-film capacitor winding coating equipment to customers [4].

国内市场需求：去年同期国内需求相对较好，今年国内需 求较为疲软，预计今年上半年国内订单需求仍然有一定压力， 下半年同期基数低，在下游需求保持稳定的情况下有望逐步改 善。 证券简称：弘亚数控 证券代码：002833 转债简称：弘亚转债 转债代码：127041 广州弘亚数控机械股份有限公司 投资者关系活动记录表 编号：20250506 投资者关系活 动类别 特定对象调研 媒体采访 新闻发布会 现场参观 分析师会议 业绩说明会 路演活动 其他 电话会议 参与单位名称 及人员姓名 详见附件 时间 2025 年 5 月 6 日 9:30 地点 公司会议室 上市公司 接待人员姓名 副总经理、董事会秘书 莫晨晓 证券部高级部长 马涵 投资者关系活 动主要内容介 绍 公司副总经理、董事会秘书莫晨晓及证券部高级部长马涵 与投资者交流了公司 2025 年第一季度经营情况，主要内容如 下： （一）报告期内公司经营情况 1、财报与业绩相关 2025 年 Q1 业绩：2025 年 1 至 3 月，公司实现营收 6.54 亿元，归母净利润 1.32 亿元，扣非净利润 1.07 亿元，经营性 现金流净额 1.4 亿元，超过归母净利润和扣非 ...

丨证券研究报告丨 公司研究丨点评报告丨宇通重工（600817.SH） [Table_Title] 信用减值损失冲回带动利润提升，拟挂牌出售环 卫业务聚焦设备主业 报告要点 [Table_Summary] 宇通重工 2025Q1 实现营业收入 7.07 亿元，同比增长 0.79%，归母净利润 0.52 亿元，同比增 长 62.47%，扣非归母净利润 0.40 亿元，同比增长 51.09%，资产减值减少及信用减值冲回两 者合计影响 Q1 税前利润 6,655.44 万元，是造成 Q1 利润大增的主要影响因素。2025Q1 公司 毛利率继续下行，费用率略有提升，公司近期挂牌出售环卫服务业务，聚焦设备主业，长期看 好公司竞争优势带动业绩回暖增长。 分析师及联系人 [Table_Author] 徐科 任楠 贾少波 李博文 盛意 SAC：S0490517090001 SAC：S0490518070001 SAC：S0490520070003 SAC：S0490524080004 SFC：BUV415 SFC：BUZ393 请阅读最后评级说明和重要声明 %% %% %% %% research.95579.com 1 宇通 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 山东威高血液净化制品股份有限公司（以下简称"威高血净"、"发行人"或"公司"）首次公开发行人民币 普通股（A股）并在主板上市（以下简称"本次发行"）的申请已经上海证券交易所（以下简称"上交 所"）上市审核委员会审议通过，并已经中国证券监督管理委员会（以下简称"中国证监会"）同意注册 （证监许可〔2025〕526号）。本次发行的保荐人（主承销商）为华泰联合证券有限责任公司（以下简 称"华泰联合证券"、"保荐人（主承销商）"）。 经发行人和保荐人（主承销商）协商确定本次发行股份数量为4,113.9407万股，全部为公开发行新股。 本次发行中，网上向持有上海市场非限售A股股份和非限售存托凭证市值的社会公众投资者定价发行与 网下向符合条件的网下投资者询价配售将于2025年5月8日（T日）分别通过上交所交易系统和上交所互 联网交易平台（IPO网下询价申购）（以下简称"互联网交易平台"）实施。 发行人和保荐人（主承销商）特别提请投资者关注以下内容： 1、本次发行采用向参与战略配售的投资者定向配售（以下简称"战略配售"）、网下向符合条件的网下 投资者询价配售（以下简称"网下 ...

Group 1 - As of May 6, 2024, 5,403 A-share listed companies have released their annual reports, with 5,087 disclosing R&D expenditure totaling 1,868.422 billion yuan, a year-on-year increase of 2.35%, with an average R&D expenditure of 36.7 million yuan [1] - 2,913 companies reported positive growth in R&D spending last year, and 260 companies saw their R&D expenditure increase by over 50% [1] - The manufacturing sector accounted for 862.630 billion yuan in R&D spending, representing 46.17% of the total disclosed R&D expenditure, with a year-on-year growth of 3.62% [1] Group 2 - BYD topped the high-end equipment manufacturing sector with R&D spending of 54.161 billion yuan, driving the Chinese electric vehicle industry towards the global value chain [2] - Companies like CATL and LONGi Green Energy have made significant investments in battery materials and photovoltaic components, creating a complete innovation chain in the new energy sector [2] - In the specialized equipment manufacturing sector, companies such as SANY Heavy Industry and Zoomlion have exceeded 10 billion yuan in R&D spending, promoting the electrification and intelligence of engineering machinery [2] Group 3 - The top 20 companies in R&D spending are concentrated in Beijing, Guangdong, and Shanghai, with Beijing having 13 companies, indicating a strong regional innovation ecosystem [3] - Increased R&D spending is expected to help companies develop more competitive products and services, enhancing market share and profitability, particularly in high-tech sectors [3] - Continuous innovation through increased R&D investment allows companies to identify new growth opportunities and maintain competitive advantages in a complex global economic environment [3]

大叶股份（300879）发布异动公告，截至2025年5月6日，公司滚动市盈率为41.85倍，静态市盈率为 428.03倍，市净率为4.93倍；根据中证指数有限公司发布数据，公司所属中上协行业分类"专用设备制造 业"最新的滚动市盈率为27.7倍，静态市盈率为28.05倍，市净率为2.85倍，公司当前滚动市盈率、静态 市盈率、市净率严重偏离同行业上市公司合理估值，郑重提醒广大投资者理性投资，注意投资风险。 ...

证券研究报告 2025 年 5 月 6 日 星期二 【新股发行跟踪（20250506）】 从周度上市新股表现来看，上上周无新股首日破发。 表 1：周度新股上市概况 | 期间 | | 新股上市数（主 | | 首发募资 | 首日破 | 首日涨超 | 首日涨跌幅范围 | 首日涨跌幅 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 板/双创） | | （亿元） | 发率 | 100%数量 | | 均值 | | | 4-28 | 至 4-30 | 0 | (0/0) | 0.00 | 0% | 0 | (0.00%，0.00%) | 至 4-28 | 4-30 | | 4-21 | 至 4-25 | 3 | (2/1) | 48.02 | 0% | 1 | (24.06%，179.39%) | 至 4-21 | 4-25 | | 4-14 | 至 4-18 | 3 | (2/1) | 11.71 | 0% | 3 | (165.08%，312.58%) | 至 4-14 | 4-18 | | 4-7 至 | 4-11 | 3 ...

Summary of Key Points Core Viewpoint - This week, three new stocks are available for subscription in the A-share market, including Hanbang Technology, Weigao Blood Purification, and Taili Technology [1][2]. Group 1: Hanbang Technology - Hanbang Technology is a leading company in chromatography equipment in China, with a subscription code of 787755 and an issue price of 22.77 yuan per share, with a P/E ratio of 26.35 times [3][6]. - The total number of shares issued is 22 million, with 5.28 million shares available for online subscription. The maximum subscription limit for investors is 5,000 shares, requiring a market value of 50,000 yuan in the Shanghai market [3][6]. - The company’s revenue is projected to grow from 482 million yuan in 2022 to 691 million yuan in 2024, with net profits increasing from 38.56 million yuan to 79.34 million yuan during the same period [7][10]. - Major clients include domestic pharmaceutical companies and international clients such as INTECH ANALYTICAL INSTRUMENTS and REETEC AS [7]. Group 2: Weigao Blood Purification - Weigao Blood Purification is a manufacturer of medical products for blood purification, with a subscription code of 732014. The total number of shares issued is 41.14 million, with 11.11 million shares available for online subscription [12][14]. - The company’s revenue is expected to rise from 3.426 billion yuan in 2022 to 3.604 billion yuan in 2024, with net profits increasing from 315.00 million yuan to 449.39 million yuan [12][14]. - Key clients include major pharmaceutical groups such as China National Pharmaceutical Group and China Resources Group [12]. Group 3: Taili Technology - Taili Technology focuses on new material research and vacuum technology applications, with a subscription code of 301595. The total number of shares issued is 27.07 million, with 6.90 million shares available for online subscription [17]. - The company’s revenue is projected to grow from 638 million yuan in 2022 to 1.020 billion yuan in 2024, with net profits increasing from 58.84 million yuan to 87.64 million yuan [17][18]. - Major clients include international retailers such as IKEA and Walmart, with Taili Technology being the exclusive supplier of vacuum bags for China's aerospace applications [17].